A detailed history of Atlanta Consulting Group Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Atlanta Consulting Group Advisors, LLC holds 14,279 shares of JNJ stock, worth $2.25 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
14,279
Previous 10,938 30.54%
Holding current value
$2.25 Million
Previous $1.6 Billion 44.75%
% of portfolio
0.57%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$145.48 - $167.38 $486,048 - $559,216
3,341 Added 30.54%
14,279 $2.31 Billion
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $15,304 - $16,724
106 Added 0.98%
10,938 $1.6 Billion
Q1 2024

Aug 26, 2024

SELL
$155.22 - $162.74 $16,453 - $17,250
-106 Reduced 0.97%
10,832 $1.71 Billion
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $1.68 Million - $1.76 Million
10,832 New
10,832 $1.71 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $413B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Atlanta Consulting Group Advisors, LLC Portfolio

Follow Atlanta Consulting Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Consulting Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Consulting Group Advisors, LLC with notifications on news.